Mercy Health - ST Vincent Medical Center LLC

Mercy Health - ST Vincent Medical Center LLC was paid $132.93M by Medicaid between Jan 2018 and Dec 2024, across 673 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.

33Billing provider infoMERCY HEALTH - ST VINCENT MEDICAL CENTER LLC
TOLEDO, OH 43608

33aNPI1467493551assigned 06/09/2006

33bProvider typeLand Ambulance

28Total paid$132.93M

24GClaims2,987,484

24DCodes billed673

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Land Ambulance providers in Ohio

Rank by total paid#1 of 257

Median peer was paid$194K

This provider vs. median686×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	244,148	$9.84M
2019	236,693	$9.81M
2020	172,711	$10.04M
2021	183,660	$10.49M
2022	318,130	$15.49M
2023	1,060,910	$45.62M
2024incomplete	771,232	$31.64M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	13%	131,512	119,531	$16.89M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	12%	111,474	92,882	$16.21M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	8.8%	71,660	58,113	$11.72M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	7.0%	101,531	87,069	$9.27M
96361	Intravenous infusion, hydration; each additional hour	4.4%	16,473	9,499	$5.90M
J9271	Injection, pembrolizumab, 1 mg	4.1%	797	454	$5.42M
70450	Computed tomography, head or brain; without contrast material	3.4%	15,467	12,335	$4.49M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.1%	55,820	15,068	$4.12M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.6%	29,981	27,617	$3.43M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.5%	11,721	8,812	$3.26M
G0378	Hospital observation service, per hour	1.9%	34,276	14,178	$2.47M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.6%	13,880	8,751	$2.14M

661 more codes

96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.5%	7,681	$2.03M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.3%	3,701	$1.67M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.1%	5,075	$1.48M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	1.1%	10,613	$1.46M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.1%	10,698	$1.42M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	6,174	$1.02M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,005	$843K
76819	Fetal biophysical profile; without non-stress testing	<1%	8,182	$812K
76820		<1%	7,865	$793K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	8,546	$764K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	2,456	$758K
80053	Comprehensive metabolic panel	<1%	90,030	$694K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,538	$667K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,236	$662K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,877	$661K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	878	$648K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	9,812	$620K
80048	Basic metabolic panel (calcium, ionized)	<1%	83,636	$583K
70496		<1%	2,165	$548K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	4,482	$541K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	4,700	$540K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	3,407	$519K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,056	$514K
99213	Doctor's office visit, returning patient (routine)	<1%	4,645	$489K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	4,686	$474K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	945	$473K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,504	$385K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,476	$385K
95811		<1%	569	$383K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	5,002	$356K
93325		<1%	2,144	$355K
64493		<1%	529	$352K
93458		<1%	313	$349K
78815	Positron emission tomography (PET) for limited area imaging	<1%	731	$346K
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	224	$339K
84443	Thyroid stimulating hormone (TSH)	<1%	19,452	$336K
70491		<1%	1,075	$326K
J0897	Injection, denosumab, 1 mg	<1%	372	$326K
41899	Unlisted procedure, dentoalveolar structures	<1%	267	$324K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,937	$323K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	160,936	$323K
71046	Radiologic examination, chest; 2 views	<1%	29,418	$321K
76821		<1%	3,649	$314K
76770		<1%	1,775	$314K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,042	$308K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	10,687	$297K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,175	$296K
76801		<1%	2,450	$296K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,403	$294K
80061	Lipid panel	<1%	12,398	$287K
84484		<1%	69,394	$280K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	2,311	$279K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,449	$274K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,749	$273K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,286	$252K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	78,005	$247K
49083		<1%	632	$246K
36415	Collection of venous blood by venipuncture	<1%	122,918	$240K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	427	$239K
64635		<1%	418	$235K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	2,466	$231K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	8,330	$227K
97161		<1%	4,708	$215K
95816		<1%	1,262	$210K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,373	$207K
93017		<1%	2,216	$204K
83036	Hemoglobin; glycosylated (A1C)	<1%	18,356	$201K
12001		<1%	1,132	$200K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	871	$190K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,843	$187K
97113		<1%	2,556	$185K
93976		<1%	1,203	$181K
76813		<1%	1,825	$174K
77386		<1%	406	$171K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	7,881	$167K
10060		<1%	922	$166K
76825		<1%	1,798	$164K
97016		<1%	5,402	$164K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	69,791	$163K
96416		<1%	533	$158K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	18,808	$155K
74174		<1%	670	$152K
96415		<1%	1,039	$151K
76827		<1%	1,894	$150K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,019	$149K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	3,633	$147K
93970		<1%	957	$147K
71045	Radiologic examination, chest; single view	<1%	36,487	$143K
90870		<1%	428	$142K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	8,238	$135K
76642		<1%	1,237	$133K
76818		<1%	1,869	$130K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	487	$129K
74018		<1%	2,857	$124K
12011		<1%	737	$123K
71250		<1%	1,436	$119K
71271		<1%	1,041	$116K
72141		<1%	785	$116K
85027		<1%	23,607	$114K
97162		<1%	3,144	$113K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	906	$110K
74183		<1%	472	$109K
72125	Computed tomography, cervical spine; without contrast material	<1%	5,686	$108K
94060		<1%	899	$108K
72131		<1%	1,694	$107K
86900		<1%	4,988	$107K
12002		<1%	613	$106K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	11,816	$100K
76536		<1%	890	$100K
52356		<1%	50	$97K
93975		<1%	652	$97K
93971		<1%	1,196	$95K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	688	$91K
96367		<1%	2,310	$87K
80320		<1%	7,726	$86K
84439		<1%	6,834	$86K
82607		<1%	5,107	$86K
87510		<1%	12,755	$84K
72100		<1%	2,961	$83K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	116	$81K
71275	Computed tomographic angiography, chest, with contrast material	<1%	678	$81K
47562		<1%	23	$79K
97535	Self-care/home management training, each 15 minutes	<1%	2,550	$78K
84702		<1%	5,151	$77K
G0008	Administration of influenza virus vaccine	<1%	7,293	$75K
73700		<1%	642	$74K
77336		<1%	782	$73K
70498		<1%	2,307	$72K
87086	Culture, bacterial; quantitative colony count, urine	<1%	24,527	$71K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	4,124	$71K
82805		<1%	1,991	$70K
73562		<1%	4,510	$67K
97116		<1%	3,188	$65K
11045		<1%	221	$65K
86780		<1%	2,737	$65K
76830	Ultrasound, transvaginal	<1%	1,824	$65K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	57,362	$65K
90686		<1%	5,552	$64K
83655		<1%	1,822	$63K
77334		<1%	135	$63K
77300		<1%	132	$62K
A9609	Fludeoxyglucose f18 up to 15 millicuries	<1%	246	$61K
83550		<1%	4,305	$61K
82728		<1%	4,515	$59K
83735		<1%	24,115	$59K
96375	Therapeutic injection; each additional sequential IV push	<1%	51,820	$59K
82746		<1%	4,116	$59K
96161		<1%	228	$58K
73630		<1%	5,119	$58K
70486		<1%	1,407	$58K
97166		<1%	1,505	$57K
82947		<1%	29,947	$56K
36430		<1%	563	$56K
73221		<1%	270	$55K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	18,179	$55K
97165		<1%	772	$55K
86140		<1%	5,706	$55K
86850		<1%	4,517	$54K
87660		<1%	12,921	$53K
58558		<1%	36	$53K
94726		<1%	803	$52K
86803		<1%	2,101	$52K
72040		<1%	1,416	$51K
73030		<1%	3,621	$51K
A0425	Ground mileage, per statute mile	<1%	994	$51K
72197		<1%	212	$50K
94729		<1%	825	$50K
80076		<1%	10,157	$50K
83970		<1%	1,519	$48K
81001		<1%	60,127	$48K
88307		<1%	544	$47K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,743	$46K
83516		<1%	2,018	$46K
94664		<1%	2,228	$45K
95951		<1%	103	$45K
85055		<1%	4,211	$44K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	18,813	$44K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	212	$43K
87506		<1%	375	$41K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,205	$41K
83540		<1%	4,723	$41K
73610		<1%	3,867	$40K
A0427	Emergency ambulance ride, advanced life support	<1%	260	$40K
93798		<1%	905	$40K
J3490	Unclassified drugs	<1%	749	$40K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	480	$39K
36591		<1%	11,245	$38K
J1756	Injection, iron sucrose, 1 mg	<1%	1,785	$38K
90670		<1%	3,889	$37K
90651		<1%	747	$37K
73130		<1%	4,403	$36K
90715		<1%	2,252	$35K
83880		<1%	9,825	$35K
73502		<1%	2,190	$34K
72128		<1%	901	$34K
88341		<1%	604	$34K
95800		<1%	124	$33K
85610		<1%	17,286	$32K
96523		<1%	538	$32K
83525		<1%	1,045	$31K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	219	$30K
36561		<1%	35	$30K
74230		<1%	235	$30K
J0588	Injection, incobotulinumtoxin a, 1 unit	<1%	33	$30K
82570		<1%	3,436	$30K
97014		<1%	1,083	$30K
93923		<1%	344	$30K
43235		<1%	95	$29K
82565		<1%	7,536	$29K
A0434	Specialty care transport (sct)	<1%	182	$29K
99204	Doctor's office visit, new patient (more involved)	<1%	292	$29K
86003		<1%	1,563	$28K
77065	Tomosynthesis, mammo	<1%	681	$28K
86480		<1%	556	$28K
77080		<1%	431	$28K
95886		<1%	271	$27K
74178		<1%	130	$27K
77066	Tomosynthesis, mammo	<1%	622	$27K
87522	Neg quan hep c or qual rna	<1%	571	$26K
64483		<1%	68	$26K
95714		<1%	20	$26K
96376		<1%	16,891	$26K
82105		<1%	1,159	$26K
99152		<1%	1,009	$26K
86225		<1%	1,069	$25K
93880		<1%	320	$25K
87340		<1%	1,854	$25K
99203	Doctor's office visit, new patient (routine)	<1%	236	$25K
74019		<1%	440	$25K
83690		<1%	38,222	$24K
83605		<1%	11,502	$24K
29881		<1%	21	$23K
84481		<1%	952	$23K
90698		<1%	3,284	$23K
99153	Mod sedat endo service >5yrs	<1%	677	$23K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,044	$23K
82784		<1%	1,465	$23K
86901		<1%	4,817	$22K
11721		<1%	801	$22K
85652		<1%	4,571	$22K
72170		<1%	636	$21K
77301		<1%	20	$21K
73110		<1%	2,489	$21K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	1,449	$20K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	149	$20K
86920		<1%	916	$20K
73080		<1%	1,622	$20K
82785		<1%	832	$20K
A0436	Rotary wing air mileage, per statute mile	<1%	222	$20K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	69	$19K
80074		<1%	965	$19K
64415		<1%	63	$19K
72156		<1%	194	$19K
90472	Immunization administration, each additional vaccine (list separately)	<1%	5,841	$19K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	52	$19K
90633		<1%	1,971	$19K
99201		<1%	212	$19K
93225		<1%	228	$19K
85730		<1%	6,822	$19K
86317		<1%	900	$18K
80051		<1%	3,310	$18K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	274	$17K
72158		<1%	125	$17K
80323		<1%	640	$17K
90744		<1%	2,119	$17K
72082		<1%	209	$16K
64447		<1%	136	$16K
81025		<1%	17,665	$16K
62323		<1%	48	$16K
52000		<1%	20	$16K
87186		<1%	4,564	$16K
87641		<1%	554	$16K
19083		<1%	15	$16K
84146		<1%	662	$16K
84703		<1%	28,034	$15K
11043		<1%	90	$15K
86038		<1%	1,047	$15K
72110		<1%	307	$15K
73590		<1%	1,553	$15K
81003		<1%	9,548	$15K
84630		<1%	583	$15K
G0009	Administration of pneumococcal vaccine	<1%	4,400	$15K
85379		<1%	8,346	$14K
84153		<1%	868	$14K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	140	$14K
72072		<1%	657	$14K
87480		<1%	12,838	$14K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	32	$14K
92611		<1%	230	$14K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,071	$13K
82043		<1%	1,815	$13K
70360		<1%	483	$13K
84403		<1%	642	$13K
86762		<1%	746	$13K
84550		<1%	1,866	$13K
87902		<1%	61	$12K
72050		<1%	241	$12K
S9445	Patient education, not otherwise classified, non-physician provider, individual, per session	<1%	253	$12K
73564		<1%	458	$12K
82533		<1%	1,601	$12K
90680		<1%	2,243	$12K
76882		<1%	101	$11K
94010		<1%	493	$11K
84590		<1%	526	$11K
73090		<1%	1,314	$10K
94660		<1%	124	$10K
73560		<1%	220	$10K
84425		<1%	661	$9K
84100		<1%	3,319	$9K
76870		<1%	598	$9K
84520		<1%	5,702	$9K
94776		<1%	159	$9K
82670		<1%	350	$9K
64450		<1%	35	$9K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,822	$9K
80164		<1%	746	$9K
90688		<1%	762	$9K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	14,425	$8K
59025	Fetal non-stress test	<1%	75	$8K
54161		<1%	15	$8K
86403		<1%	1,667	$8K
77338		<1%	21	$8K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	15,859	$8K
76775		<1%	85	$8K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,575	$8K
83001		<1%	474	$8K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	9,827	$8K
82330		<1%	2,880	$8K
87077		<1%	2,933	$8K
85045		<1%	1,418	$8K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	18,623	$8K
82248		<1%	792	$7K
86376		<1%	354	$7K
G0010	Administration of hepatitis b vaccine	<1%	2,089	$7K
73140		<1%	276	$7K
00731		<1%	2,721	$7K
86147		<1%	221	$7K
73552		<1%	684	$7K
73100		<1%	164	$7K
72146		<1%	64	$7K
84156		<1%	1,686	$7K
81241		<1%	97	$6K
92587		<1%	54	$6K
86704		<1%	376	$6K
92551		<1%	65	$6K
82140		<1%	1,107	$6K
J1170	Injection, hydromorphone, up to 4 mg	<1%	7,259	$6K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	240	$6K
83002		<1%	372	$6K
J1453	Injection, fosaprepitant, 1 mg	<1%	527	$6K
85014		<1%	4,086	$5K
86787		<1%	156	$5K
64400		<1%	25	$5K
87040		<1%	4,454	$5K
71101		<1%	667	$5K
97163		<1%	91	$5K
84132		<1%	2,825	$5K
86334		<1%	272	$5K
84460		<1%	793	$5K
86431		<1%	274	$5K
95819		<1%	29	$5K
83521		<1%	679	$5K
82977		<1%	436	$5K
64636		<1%	416	$5K
90677		<1%	19	$5K
92523		<1%	81	$5K
84165		<1%	547	$5K
82378		<1%	647	$4K
73060		<1%	653	$4K
51798		<1%	706	$4K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,379	$4K
74022		<1%	602	$4K
J1953	Injection, levetiracetam, 10 mg	<1%	825	$4K
82550		<1%	2,189	$4K
81002		<1%	670	$4K
75574		<1%	13	$4K
90696		<1%	451	$4K
82950		<1%	335	$4K
88172		<1%	42	$4K
83615		<1%	954	$4K
90685		<1%	427	$4K
84480		<1%	150	$4K
90710		<1%	703	$4K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,088	$4K
80177		<1%	1,043	$4K
84450		<1%	679	$4K
83520		<1%	132	$4K
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	<1%	46	$3K
87088		<1%	1,752	$3K
80143		<1%	3,456	$3K
C1776	Joint device (implantable)	<1%	297	$3K
85018		<1%	1,707	$3K
97802		<1%	40	$3K
20610		<1%	42	$3K
83883		<1%	73	$3K
87070		<1%	1,440	$3K
82803		<1%	2,150	$3K
84145		<1%	1,013	$3K
77072		<1%	40	$3K
90716		<1%	356	$3K
96368		<1%	1,301	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	45,982	$3K
86695		<1%	146	$3K
J9045	Injection, carboplatin, 50 mg	<1%	258	$3K
93226		<1%	55	$3K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	324	$3K
87205		<1%	1,877	$3K
83874		<1%	2,644	$3K
86696		<1%	146	$3K
12013		<1%	16	$3K
76981		<1%	30	$3K
83013		<1%	42	$2K
86694		<1%	130	$2K
87449		<1%	380	$2K
78264		<1%	13	$2K
97750		<1%	31	$2K
73718		<1%	14	$2K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,676	$2K
81000		<1%	246	$2K
82435		<1%	988	$2K
85049		<1%	1,069	$2K
69210		<1%	99	$2K
82310		<1%	429	$2K
86708		<1%	80	$2K
90707		<1%	351	$2K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	304	$2K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	17	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	23,681	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,066	$2K
86644		<1%	92	$2K
76885		<1%	12	$2K
81240		<1%	67	$2K
87324		<1%	260	$2K
82652		<1%	81	$2K
J2704	Injection, propofol, 10 mg	<1%	22,869	$2K
00400		<1%	530	$2K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,000	$2K
86777		<1%	63	$2K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	20	$2K
84295		<1%	1,318	$2K
80179		<1%	3,390	$2K
84436		<1%	187	$2K
90734		<1%	337	$2K
86665		<1%	65	$2K
80326		<1%	185	$2K
82951		<1%	53	$2K
84270		<1%	66	$1K
88280		<1%	15	$1K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,180	$1K
90700		<1%	206	$1K
86308		<1%	528	$1K
76937		<1%	76	$1K
90714		<1%	90	$1K
90732		<1%	79	$1K
86645		<1%	79	$1K
82627		<1%	69	$1K
82150		<1%	1,955	$1K
77073		<1%	17	$1K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	238	$1K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	26,114	$1K
G0379	Direct admission of patient for hospital observation care	<1%	154	$1K
82040		<1%	481	$1K
64494		<1%	516	$1K
86800		<1%	70	$1K
00910		<1%	514	$1K
86778		<1%	61	$1K
64445		<1%	29	$1K
96417		<1%	1,225	$1K
73620		<1%	51	$1K
87075		<1%	943	$1K
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	13	$1K
82103		<1%	92	$1K
82247		<1%	151	$1K
86160		<1%	102	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,113	$1K
76942		<1%	233	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	44,545	$994.20
01992		<1%	184	$980.24
90648		<1%	102	$979.80
83721		<1%	58	$968.24
83020		<1%	50	$966.50
80175		<1%	220	$961.11
83090		<1%	73	$953.16
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	13,019	$943.49
80355		<1%	127	$932.71
C1769	Guide wire	<1%	1,868	$921.11
82397		<1%	33	$905.25
83993		<1%	44	$897.99
C1889	Implantable/insertable device, not otherwise classified	<1%	547	$893.94
86304		<1%	51	$853.46
86747		<1%	52	$845.17
97597		<1%	23	$840.37
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	2,650	$839.57
88342		<1%	1,795	$831.77
00940		<1%	25	$806.24
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	20,438	$787.35
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	363	$777.13
97035		<1%	64	$775.64
72120		<1%	16	$774.11
72070		<1%	37	$754.26
J1644	Injection, heparin sodium, per 1000 units	<1%	5,415	$704.12
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,796	$701.78
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	13,739	$647.54
80347		<1%	82	$645.77
J1456	Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg	<1%	96	$633.37
82952		<1%	39	$632.12
J2550	Injection, promethazine hcl, up to 50 mg	<1%	1,771	$605.80
73521		<1%	13	$600.10
73000		<1%	19	$596.54
87807		<1%	1,161	$583.85
85613		<1%	84	$583.81
29125		<1%	760	$582.64
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	886	$554.47
01480		<1%	379	$533.44
90620		<1%	51	$529.40
82962		<1%	260	$527.07
90746		<1%	31	$496.82
85576		<1%	20	$495.50
85300		<1%	42	$492.15
C9113	Injection, pantoprazole sodium, per vial	<1%	946	$488.88
90846	Family psychotherapy without the patient present, 50 minutes	<1%	14	$477.45
72220		<1%	45	$471.18
82010		<1%	1,339	$461.35
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,733	$452.28
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	791	$450.01
77002		<1%	13	$445.42
85306		<1%	63	$435.86
84155		<1%	79	$427.18
83010		<1%	36	$402.73
00813		<1%	1,076	$395.59
01400		<1%	52	$395.59
00840		<1%	338	$395.59
00811		<1%	937	$395.59
00812		<1%	806	$395.59
83527		<1%	20	$354.26
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,029	$341.14
85651		<1%	138	$338.91
82270		<1%	111	$338.22
83930		<1%	154	$332.47
82390		<1%	25	$326.80
93320		<1%	40	$316.50
J0280	Injection, aminophyllin, up to 250 mg	<1%	88	$311.60
88112		<1%	18	$301.14
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,327	$296.81
84305		<1%	13	$288.37
J2060	Injection, lorazepam, 2 mg	<1%	3,074	$286.91
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,974	$273.82
80364		<1%	82	$267.32
00104		<1%	242	$266.72
86301		<1%	33	$242.24
85303		<1%	35	$239.17
74220		<1%	14	$227.51
88304		<1%	867	$223.99
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,830	$220.12
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,084	$217.07
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	375	$213.46
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,388	$208.44
84300		<1%	135	$194.44
73600		<1%	20	$182.92
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	1,119	$182.82
J2470	Injection, pantoprazole sodium, 40 mg	<1%	354	$180.22
84478		<1%	27	$171.32
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	2,818	$164.37
J1790	Injection, droperidol, up to 5 mg	<1%	1,372	$163.40
86300		<1%	43	$160.73
82272		<1%	33	$153.43
87076		<1%	60	$152.33
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	292	$149.83
77001		<1%	45	$149.82
96402		<1%	18	$139.40
73070		<1%	17	$120.01
J3480	Injection, potassium chloride, per 2 meq	<1%	1,816	$116.19
84075		<1%	32	$114.38
82274		<1%	12	$112.97
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,712	$112.96
80235		<1%	18	$112.60
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	731	$102.47
87081		<1%	19	$93.12
88173		<1%	67	$89.48
J1630	Injection, haloperidol, up to 5 mg	<1%	1,057	$82.69
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	146	$80.79
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,034	$80.68
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	204	$74.08
94761		<1%	4,269	$66.48
51702		<1%	49	$66.06
J1940	Injection, furosemide, up to 20 mg	<1%	589	$59.89
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	693	$59.61
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,056	$59.57
J3411	Injection, thiamine hcl, 100 mg	<1%	756	$58.11
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	870	$56.64
64484		<1%	19	$54.72
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,695	$54.57
80165		<1%	18	$47.86
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	13	$41.44
87184		<1%	17	$37.90
85384		<1%	14	$36.44
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	562	$32.90
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	378	$31.03
J8501	Aprepitant, oral, 5 mg	<1%	13	$29.10
82553		<1%	80	$27.20
J1171	Injection, hydromorphone, 0.1 mg	<1%	419	$26.39
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	536	$25.30
J7050	Infusion, normal saline solution, 250 cc	<1%	1,498	$25.11
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	2,675	$24.99
82800		<1%	73	$24.13
82375		<1%	13	$23.15
J9190	Injection, fluorouracil, 500 mg	<1%	917	$20.16
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	98	$17.86
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	<1%	208	$14.51
J0456	Injection, azithromycin, 500 mg	<1%	180	$13.72
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,506	$13.59
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	543	$13.21
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	514	$12.45
89051		<1%	33	$11.35
J2305	Injection, nitroglycerin, 5 mg	<1%	191	$10.88
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	286	$10.50
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	15	$9.56
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	490	$8.49
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	248	$8.36
J0461	Injection, atropine sulfate, 0.01 mg	<1%	53	$6.30
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	347	$5.44
H1000	Prenatal care, at-risk assessment	<1%	138	$4.49
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	625	$1.42
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	17	$0.14
96411		0%	274	$0.00
C1781	Mesh (implantable)	0%	94	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	1,148	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	97	$0.00
88311		0%	16	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	265	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	424	$0.00
94760		0%	1,079	$0.00
00790		0%	298	$0.00
94762		0%	241	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	111	$0.00
00952		0%	143	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	44	$0.00
J7999	Compounded drug, not otherwise classified	0%	57	$0.00
C9399	Unclassified drugs or biologicals	0%	126	$0.00
A4648	Tissue marker, implantable, any type, each	0%	70	$0.00
84157		0%	14	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	79	$0.00
00170	Anesthesia for intraoral procedures, including biopsy	0%	393	$0.00
64495		0%	209	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	39	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	14	$0.00
00300		0%	182	$0.00
01810		0%	110	$0.00
C1758	Catheter, ureteral	0%	375	$0.00
88360		0%	18	$0.00
00920		0%	143	$0.00
00918		0%	86	$0.00
C1788	Port, indwelling (implantable)	0%	18	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	436	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	42	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	34	$0.00
85520		0%	31	$0.00
C1729	Catheter, drainage	0%	36	$0.00
A4641	Radiopharmaceutical, diagnostic, not otherwise classified	0%	37	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	42	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	26	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDEMPSEY, JEFFREY (PRESIDENT ST VINCENT MEDICAL CENTER)